The Pharma Paradigm: Why Public AI is a Compliance Failure
Pharmaceutical manufacturing operating under USFDA guidelines faces a critical hurdle with modern technology: **The Data Ownership Paradox.** While generative AI could save thousands of hours in audit preparations, traditional cloud-hosted AI endpoints run directly counter to information privacy rules.
1. Intellectual Property & Batch Record Vulnerability
Uploading master batch records, clinical testing protocols, or manufacturing formulas to commercial AI APIs fundamentally compromises data boundaries. Rauzr prevents external processing risks completely.
2. Real-Time SOP Cross-Referencing Friction
When corporate operating guidelines change, cross-checking old operational protocols takes QA leads weeks of manual tracing. Our systems run semantic gap analyses locally to identify processing conflicts in seconds.
3. Full USFDA 21 CFR Part 11 Readiness
Generic AI tools lack context tracking. Rauzr is designed specifically to output deterministic log chains, capturing every user input and document chunk hash natively.